Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Dec 08, 2025

SELL
$1.25 - $2.35 $22,055 - $41,463
-17,644 Reduced 25.35%
51,949 $112 Million
Q3 2023

Dec 08, 2025

SELL
$1.5 - $3.07 $13,419 - $27,464
-8,946 Reduced 11.39%
69,593 $113 Million
Q1 2023

Dec 08, 2025

BUY
$2.65 - $3.81 $208,128 - $299,233
78,539 New
78,539 $193 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Nwf Advisory Services Inc. Portfolio

Follow Nwf Advisory Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwf Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nwf Advisory Services Inc. with notifications on news.